RACORDIAX is a product of BacTrace BioTec AG
RACORDIAX
The digital, fast and accurate method to detect COVID-19 antibodies.
RACORDIAX is a product of BacTrace BioTec AG
RACORDIAX
The digital, fast and accurate method to detect COVID-19 antibodies.
The RACORDIAX COVID-19 antibody rapid test was developed to simultaneously analyze the current status of IgM, IgG and IgA antibodies as quickly and accurately as possible via a digital platform.
Manufactured in Germany, the CE-marked test provides a test result with 99.41% sensitivity and 99.13% specificity in just 10 minutes, using the appropriate smartphone iOS or Android RACORDIAX App.
Partnerships
BacTrace BioTec AG works closely with a renowned and decorated Scientific Advisory Board as well as with internationally recognized universities and scientific institutions.
- Prof. Dr. Dr. h.c. mult. Willi Jäger, Universität Heidelberg
- Dipl.-Ing. Manfred Opel, Brigade General a.D.
- Prof. Dr. Valentin N. Pavlov, Bashkir State Medical University
- Priv.-Doz. Dr. med. Michael T. Pawlik, Universität Regensburg
- Dr. med. Sören Wagner, Harvard Medical School
- Prof. Dr. med. Dr. h.c. mult. Wolf F. Wieland, Universität Regensburg
- Dr. med. Hans Hermann Wörl
-
BacTrace BioTec AG
Autharistrasse 31
81545 Munich
Germany
- General Information
- info@bactrace.de
- +49 (0) 89 540 464-13
- Sales and Marketing
- sales@bactrace.de
- +49 (0) 89 540 464-13
- Public Relations
- press@bactrace.de
- +49 (0) 89 540 464-13